Deepinder Goyal built an app that fed Indians. With Temple, can he fix how they age?
About this episode
Deepinder Goyal, the founder of Zomato, has a new startup. It's called Temple — a wearable that tracks blood flow in your brain. His theory is that improving that flow could slow down aging. Doctors aren't convinced. Investors seem to be.
Temple is valued at 190 million dollars. The science behind it hasn't been peer reviewed. And India has a rapidly aging population that could genuinely use some answers.
So who exactly is this for?
Tune in.
Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.
Get every episode summarized
Each time Daybreak publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Daybreak
This week in AI: activist robots, doom-laden researchers — so who's the good guy...
Daybreak
India has more tourists than ever. So why is tourism in trouble?
Daybreak
The Government sold Air India to escape its problems. The fix is to buy back in
Daybreak
Nykaa cracked fashion at last. Myntra sees no reason to panic
Daybreak